| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |